AI eye doctor: new study aims to spot Blindness-Causing diseases

NCT ID NCT07497815

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will develop and test an artificial intelligence system to detect common eye diseases like glaucoma, cataracts, and diabetic retinopathy using 15,000 existing eye images from Costa Rican patients. The goal is to create a tool that works accurately for local populations, since AI systems trained on other ethnic groups may not perform as well. No new treatments or patient contact are involved—it's purely a diagnostic technology validation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a reliable AI tool for diagnosing eye diseases in Latin American populations, improving early detection and reducing blindness.
What could go wrong
This is an early-stage observational study using existing images, not a clinical treatment trial. The AI may not perform as well in real-world settings or on different populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asociados de Mácula y Vítreo de Costa Rica

    San José, Provincia de San José, Costa Rica

  • Centro Ocular

    Heredia, Centro, Costa Rica

More trials for these conditions

Other studies related to the condition(s) this trial covers.